Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2014 | 12-2013 | 09-2013 | 06-2013 | 03-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 182,973 | 237,179 | 284,436 | 331,891 | 373,301 |
| Marketable Securities | N/A | N/A | 10,007 | 20,016 | 25,027 |
| Receivables | 4,241 | 1,305 | 7,024 | 4,888 | 5,514 |
| Inventories | 480 | 419 | 577 | 716 | 2,430 |
| Other current assets | 11,301 | 6,043 | 11,344 | 10,623 | 8,724 |
| TOTAL | $198,995 | $244,946 | $313,388 | $368,134 | $414,996 |
| Non-Current Assets | |||||
| PPE Net | 129,961 | 108,777 | 75,611 | 55,058 | 27,209 |
| Intangibles | 5,340 | 5,814 | 0 | 0 | 0 |
| Other Non-Current Assets | 11,359 | 11,357 | 17,815 | 12,578 | 10,155 |
| TOTAL | $146,660 | $125,948 | $93,426 | $67,636 | $37,364 |
| Total Assets | $345,655 | $370,894 | $406,814 | $435,770 | $452,360 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,375 | 4,200 | 3,675 | 3,150 | 2,625 |
| Accounts payable and accrued liabilities | 13,196 | 11,363 | 15,926 | 11,228 | 10,251 |
| Accrued Expenses | 24,399 | 29,518 | 30,403 | 30,771 | 23,995 |
| Other current liabilities | 14,369 | 15,136 | 5,634 | 2,955 | 1,325 |
| TOTAL | $67,129 | $72,177 | $73,033 | $65,490 | $53,291 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,675 | 4,900 | 5,950 | 7,000 | 8,050 |
| Deferred Revenues | 2,656 | 2,983 | 7,498 | 5,855 | 7,196 |
| Other Non-Current Liabilities | 8,545 | 8,580 | 6,917 | 6,594 | 6,557 |
| TOTAL | $133,335 | $113,200 | $79,960 | $60,566 | $35,093 |
| Total Liabilities | $200,464 | $185,377 | $152,993 | $126,056 | $88,384 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 186,798 | 186,323 | 185,656 | 185,107 | 184,691 |
| Common Shares | 187 | 186 | 186 | 185 | 185 |
| Retained earnings | -1,101,815 | -1,051,993 | -977,830 | -911,490 | -842,505 |
| Other shareholders' equity | -1,495 | -1,535 | -27 | -18 | 38 |
| TOTAL | $145,191 | $185,517 | $253,821 | $309,714 | $363,976 |
| Total Liabilities And Equity | $345,655 | $370,894 | $406,814 | $435,770 | $452,360 |